Clinical trials
Phase 1 Leiomyosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Baylor College of Medicine | 2 |
| National Cancer Institute (NCI) | 2 |
| University of Miami | 2 |
| Valerio Therapeutics | 2 |
| Boundless Bio, Inc. | 1 |
| Catherine Bollard | 1 |
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leiomyosarcoma | 26 |
| Sarcoma | 15 |
| Liposarcoma | 12 |
| Histiocytoma, Malignant Fibrous | 11 |
| Sarcoma, Synovial | 8 |
| Dermatofibrosarcoma | 5 |
| Fibrosarcoma | 5 |
| Hemangiosarcoma | 5 |
| Neurofibrosarcoma | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.